Connexion
M'inscrire

Votre recherche

Filtres

Project précédent
Projet suivant
Nous verifions auprès de chaque centre si des nouvelles informations sont disponibles

23-007061

Une étude sur la neurodégénérescence et les fluctuations neuronales dans la maladie à corps de lewy et la maladie d'alzheimer
Source : traduction non-officielle opérée par intelligence artificielle
voir le texte original

a study of neurodegeneration and neuronal fluctuations in lewy body disease and alzheimer's disease

Référence clinicaltrials.gov: NCT06057909
Maladie à corps de Lewy
Maladie d'Alzheimer
Sain
Recrutement ouvert
Dernière modification : 2026/02/02
Type de recherche

Observationnel


Population cible

Condition médicale (spécialité visée)

Choix aire thérapeutique

Maladie à corps de Lewy

Maladie d'Alzheimer

Sain

Source : Importé depuis le centre

Profil des participants

Limites d'âge
minimum : 50 ans maximum : 95 ans
Sexe(s) des participants

Tous

Source : Importé depuis le centre

Critères de sélection

Critères d'inclusion

Inclusion Criteria:

* Use English as their primary language.
* Be willing to undergo health and cognitive assessments, as well as brain MRI and EEG study.
* Will be encouraged to have an available study partner (also called a "co-participant") who is familiar with the participant's daily functioning.
* This study will be limited to healthy individuals, and patients who have a clinical diagnosis made by a board-certified neurologist of Lewy body disease or Alzheimer disease.
* All individuals must be capable of providing informed consent and complying with the trial procedures. Realizing the challenge of obtaining informed consent from cognitively impaired individuals, time is specifically scheduled to foster an informative, supportive interview with the participant and caregiver/legal guardian (typically a spouse or child according to Arizona law and IRB guidelines).
* Ongoing participation will be maintained by strict adherence to inclusion/exclusion criteria, clinical appropriateness (as determined by participant's physician and proxy/family), as well as by expressed wishes of family members/caregivers/proxy discussed at each study visit (as appropriate).
* All participants will receive copies of the signed ICFs (including signatures of those obtaining consent).
* All participants have the right to withdraw from the study at any time.

Exclusion Criteria:

* Individuals will be excluded if they have significant sensory (visual and hearing) deficits or major medical or psychiatric illnesses which would limit participation.
* Participants will also be excluded if they have history of other major neurologic disorders including stroke, epilepsy, meningitis/encephalitis, metabolic or toxic encephalopathy, penetrating or severe closed head injury, brain tumor/other structural lesion, other primary movement disorders (such as essential tremor, dystonia, chorea, multiple system atrophy, progressive supranuclear palsy, corticobasal syndrome).
* In addition, as necessitated by the risks of Magnetic Resonance Imaging (MRI), patients who have any type of implanted electrical device (such as a cardiac pacemaker or a neurostimulator including deep brain stimulation), or a certain type of metallic clip in their body (i.e., an aneurysm clip in the brain), are not eligible for participation in the MRI portion of the study. Individuals who experience claustrophobic anxiety will also be excluded from participation.
* Women who are or might be pregnant and nursing mothers are not eligible.
* If the subject is a woman of childbearing potential, due to unknown risks to the fetus, they must have a pregnancy test. Individuals who have a history metalworking involving cutting processes such as grinding, filing, shaving, and threading, or history of eye injury involving metal, will also be excluded unless they have had prior documented radiological clearance for MRI.

Source : Importé depuis le centre

Thérapie ou Intervention proposée

Cohortes
Nom Condition médicale Traitement État du recrutement
Lewy Body Disease Group Subjects identified by their physician with a diagnosis of Lewy body disease will have a physical and neurological exam, MRI of brain, electroencephalography (EEG), and electromyography (EMG). Donnée non disponible
  • Inconnu
  • Alzheimer Disease Group Subjects identified by their physician with a diagnosis of Alzheimer will have a physical and neurological exam, MRI of brain, electroencephalography (EEG), and electromyography (EMG). Donnée non disponible
  • Inconnu
  • Healthy Control Group Subjects identified as a health individual will have a physical and neurological exam, MRI of brain, electroencephalography (EEG), and electromyography (EMG). Donnée non disponible
  • Inconnu
  • Lewy Body Disease Group
    État du recrutement
    unknown
    Alzheimer Disease Group
    État du recrutement
    unknown
    Healthy Control Group
    État du recrutement
    unknown
    Données à jour depuis : 2 février 2026

    Description de l'étude

    Résumé de l'étude

    The purpose of this research study is to investigate how the brain, memory, thinking, and motor behavior change both in individuals with movement and/or cognitive disorders, as well as healthy individuals. Researchers will look at measurements of memory, thinking, brain wave and muscle activity, daily functioning, and brain scans to learn more about brain disorders such as Alzheimer disease and Lewy body disease.

    Source : Importé depuis le centre

    Sites

    Centres participants


    Dernière modification : 2 février 2026
    Données à jour depuis : 4 fév.
    Origine des données : clinicaltrials.gov
    Référence clinicaltrials.gov: NCT06057909